Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Health

New Market Report Now Available: EpiCast Report: Dry Eye Syndrome - Epidemiology Forecast to 2022


Print article Print article
2013-04-19 18:13:50 - New Pharmaceuticals research report from GlobalData is now available from Fast Market Research

Dry eye syndrome, also known as keratoconjunctivitis sicca (KCS), is a multi-factorial disease of the eye caused by dryness, decreased tear production, or increased tear film evaporation. It results in symptoms of discomfort such as visual disturbance and tear film instability (DEWS, 2007). Middle-aged and older adults are the most commonly affected group because of the high prevalence of contact lens usage, systemic drug effects, autoimmune diseases, and refractive surgeries in these group (Davis, 2003; Glasson et al., 2003; Schaumberg et al., 2002; Schaumberg et al., 2003; Toda et al., 2001).

Globally, dry eye has a prevalence of up to 33% (Clegg et al., 2006; Lemp et al., 2008; Schaumberg et al., 2002; Shimmura et al., 1999). The prevalence of dry

eye is estimated to range from30% in various ages groups worldwide (Clegg et al., 2006; Lemp et al., 2008; Shimmura et al., 1999). Research also shows that dry eye syndrome is more prevalent in women than in men (Schaumberg et al., 2002).


Full Report Details at
- www.fastmr.com/prod/585877_epicast_report_dry_eye_syndrome_epide ..


Scope

* The Dry Eye Syndrome, EpiCast Report provides an overview of the risk factors and global trends of dry eye syndrome in the nine major markets (US, France, Germany, Italy, Spain, UK, Japan, China, and India).
* It also includes a 10-year epidemiology forecast of the prevalent cases of dry eye syndrome, segmented by age (given in five-year increments beginning at age 45 years and ending at ages 85 years and older), sex, and severity in these markets.

Reasons to buy

* Develop business strategies by understanding the trends shaping and driving the global dry eye syndrome market.
* Quantify patient populations in the global dry eye syndrome market to improve product design, pricing, and launch plans.
* Organize sales and marketing efforts by identifying the age groups, sex, and severity levels that present the best opportunities for dry eye syndrome therapeutics in each of the markets covered.

Report Table of Contents:

1 Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Catalyst
2.2 Upcoming Reports
3 Epidemiology
3.1 Risk Factors and Comorbidities
3.1.1 Risk of dry eye syndrome increases 35% each decade after age 40
3.1.2 Women are twice as likely to have dry eye syndrome as men
3.1.3 Use of certain medications may increase the risk of developing dry eye syndrome
3.1.4 Diets rich in omega-3 fatty acid may prevent dry eye syndrome
3.1.5 Certain environmental conditions can double the risk of dry eye syndrome
3.2 Global Trends
3.2.1 US
3.2.2 5EU
3.2.3 Asia
3.3 Forecast Methodology
3.3.1 Sources used
3.3.2 Forecast Assumptions and Methods
3.3.3 Sources Not Used
3.4 Epidemiology Forecast (2012-2022)
3.4.1 Prevalent Cases of Dry Eye Syndrome
3.4.2 Age-Specific Prevalent Cases
3.4.3 Sex-Specific Prevalent Cases
3.4.4 Age-Standardized Prevalence of Dry Eye Syndrome
3.4.5 Prevalent Cases of Dry Eye Syndrome by Severity
3.5 Discussion
3.5.1 Conclusions on Epidemiology Trends
3.5.2 Limitations of Analysis
3.5.3 Strengths of Analysis
4 Appendix
4.1 Bibliography
4.2 About the Authors
4.2.1 Epidemiologists
4.2.2 Reviewers
4.2.3 Global Director of Epidemiology and Clinical Trials Analysis
4.2.4 Global Head of Healthcare
4.3 About GlobalData
4.4 About EpiCast
4.5 Contact Us
4.6 Disclaimer

List of Tables

1.1 List of Tables
Table 1: Risk Factors and Comorbidities for Dry Eye Syndrome
Table 2: Sources of Epidemiology Data Used for the Forecast
Table 3: 9MM, Prevalent Cases of Dry Eye Syndrome, Ages ≥45 Years, Men and Women, N (Millions), 2012-2022
Table 4: 9MM, Prevalent Cases of Dry Eye Syndrome, By Age, Men and Women, N (Millions) (Row %), 2012
Table 5: 9MM, Prevalent Cases of Dry Eye Syndrome, By Sex, Ages ≥45 Years, N (Millions) (Row %), 2012
Table 6: 9MM, Prevalent Cases of Dry Eye Syndrome, By Severity, Ages ≥45 Years, N (Millions) (Row %), 2012

List of Figures

1.2 List of Figures
Figure 1: 9MM, Prevalent Cases of Dry Eye Syndrome, Ages ≥45 Years, Men and Women, N (Millions), 2012-2022
Figure 2: 9MM, Prevalent Cases of Dry Eye Syndrome, By Age, N (Millions), 2012
Figure 3: 9MM, Prevalent Cases of Dry Eye Syndrome, By Sex, Ages ≥45 Years, N (Millions), 2012
Figure 4: 9MM, Age-Standardized Prevalence of Dry Eye Syndrome, Ages ≥45 Years, By Sex, 2012
Figure 5: 9MM, Prevalent Cases of Dry Eye Syndrome, By Severity, Ages ≥45 Years, N (Millions), 2012

About GlobalData

GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team. View more research from GlobalData at www.fastmr.com/catalog/publishers.aspx?pubid=1015

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com